AstraZeneca PLC (AZN)
Last Price$74.20.9%
Market Cap$460.2B
LTM Quick ratio
0.2x
5Y avg
0.6x
Drug Manufacturers - General industry
median
0.8x
Stock quality & Intrinsic value
7/10
(0.6%) overvalued
AstraZeneca PLC Quick ratio
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quick ratio | 1.0x | 1.0x | 1.4x | 0.8x | 0.9x | 0.6x | 1.4x | 0.8x | 1.0x | 1.0x | 0.7x | 0.8x | 0.6x | 0.4x | 0.5x | 0.5x | 0.6x | 0.6x | 0.5x | 0.5x |
Overvalued or undervalued?
Check the intrinsic value for AZN
and see if it's the right time to invest.
AstraZeneca PLC (AZN) Quick ratio comparison analysis
Crunching data... Almost there!
AZN key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is AstraZeneca PLC's Quick ratio?
As of today, Microsoft Corp's last 12-month Quick ratio is 0.2x, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Quick ratio for AstraZeneca PLC have been 0.6x over the past three years, and 0.6x over the past five years.
2) Is AstraZeneca PLC's Quick ratio Good?
As of today, AstraZeneca PLC's Quick ratio is 0.2x, which is lower than industry median of 0.8x. It indicates that AstraZeneca PLC's Quick ratio is Bad.